医学
炎症性肠病
重症监护医学
炎症性肠病
疾病
疾病管理
溃疡性结肠炎
病理
帕金森病
作者
Florian Grimpen,Paul Pavli
标识
DOI:10.1111/j.1445-5994.2010.02163.x
摘要
Our understanding of inflammatory bowel diseases (IBD) is constantly evolving, and many new treatment options have emerged recently. This review critically examines the evidence for these new developments and aims to provide an overview for medical professionals involved in the care of patients with IBD. Proposed changes in the use of aminosalicylates, immunosuppressants and biological agents are described, and the evidence for several promising novel agents is reviewed.
科研通智能强力驱动
Strongly Powered by AbleSci AI